The objective of this study was to determine the molecular
mechanisms underlying chronic liver injury and fibrosis
caused by hepatitis C virus (HCV). This study revealed that
miR-192 expression was induced by HCV infection without
affecting viral replication. However, viral-induced miR-192
up-regulated transforming growth factor-β1 (TGF-β1) expression
in liver cells at transcriptional level. TGF-β1 stimulation
by HCV-induced miR-192 was caused through ZEB1
down-regulation and TGF-β1 increased miR-192 level via
positive feedback pathway. Increase in miR-192 expression
by HCV infection was due to HCV core protein released
and/or expressed by viral infection. TGF-β1 promoter activity
was also increased by HCV core protein in liver cells.
Taken together, HCV infection resulted in increased TGF-β1
transcription in hepatocytes through ZEB1 down-regulation
by HCV core-mediated miR-192 stimulation. Importantly,
miR-192 inhibition with anti-miR-192 rescued ZEB1 expression
down-regulated by HCV infection, thus reducing the
level of TGF-β1 expression increased by HCV infection in
hepatocytes. These results suggest a novel mechanism of
HCV-mediated liver fibrogenesis with miR-192 being a potential
molecular target to ameliorate viral pathogenesis.
Citations
Citations to this article as recorded by
Hepatitis C Virus—Core Antigen: Implications in Diagnostic, Treatment Monitoring and Clinical Outcomes Duong Hoang Huy Le, Sitthichai Kanokudom, Ha Minh Nguyen, Ritthideach Yorsaeng, Sittisak Honsawek, Sompong Vongpunsawad, Yong Poovorawan Viruses.2024; 16(12): 1863. CrossRef
Hepatocytes infected with hepatitis C virus change immunological features in the liver microenvironment Soo-Jeung Park, Young S. Hahn Clinical and Molecular Hepatology.2023; 29(1): 65. CrossRef
Cancer Stem Cell and Hepatic Stellate Cells in Hepatocellular Carcinoma Adriana G. Quiroz Reyes, Sonia A. Lozano Sepulveda, Natalia Martinez-Acuña, Jose F. Islas, Paulina Delgado Gonzalez, Tania Guadalupe Heredia Torres, Jorge Roacho Perez, Elsa N. Garza Treviño Technology in Cancer Research & Treatment.2023;[Epub] CrossRef
Circulating miRNA-192 and miR-29a as Disease Progression Biomarkers in Hepatitis C Patients with a Prevalence of HCV Genotype 3 Amin Ullah, Irshad Ur Rehman, Katharina Ommer, Nadeem Ahmed, Margarete Odenthal, Xiaojie Yu, Jamshaid Ahmad, Tariq Nadeem, Qurban Ali, Bashir Ahmad Genes.2023; 14(5): 1056. CrossRef
Rotavirus-Mediated Suppression of miRNA-192 Family and miRNA-181a Activates Wnt/β-Catenin Signaling Pathway: An In Vitro Study Anwesha Banerjee, Mamta Chawla-Sarkar, Anupam Mukherjee Viruses.2022; 14(3): 558. CrossRef
Roles of microRNAs in Hepatitis C Virus Replication and Pathogenesis Hui-Chun Li, Chee-Hing Yang, Shih-Yen Lo Viruses.2022; 14(8): 1776. CrossRef
ZEB1 serves an oncogenic role in the tumourigenesis of HCC by promoting cell proliferation, migration, and inhibiting apoptosis via Wnt/β-catenin signaling pathway Liang-yun Li, Jun-fa Yang, Fan Rong, Zhi-pan Luo, Shuang Hu, Hui Fang, Ying Wu, Rui Yao, Wei-hao Kong, Xiao-wen Feng, Bang-jie Chen, Jun Li, Tao Xu Acta Pharmacologica Sinica.2021; 42(10): 1676. CrossRef
miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation Michela Bulfoni, Riccardo Pravisani, Emiliano Dalla, Daniela Cesselli, Masaaki Hidaka, Carla Di Loreto, Susumu Eguchi, Umberto Baccarani Journal of Medical Virology.2021; 93(8): 4992. CrossRef
Complexation with Random Methyl-β-Cyclodextrin and (2-Hidroxypropyl)-β-Cyclodextrin Enhances In Vivo Anti-Fibrotic and Anti-Inflammatory Effects of Chrysin via the Inhibition of NF-κB and TGF-β1/Smad Signaling Pathways and Modulation of Hepatic Pro/Anti-F Alina Ciceu, Cornel Balta, Hidegard Herman, Sami Gharbia, Simona-Rebeca Ignat, Sorina Dinescu, Judit Váradi, Ferenc Fenyvesi, Szilvia Gyöngyösi, Anca Hermenean, Marieta Costache International Journal of Molecular Sciences.2021; 22(4): 1869. CrossRef
HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development Devis Pascut, Minh Hoang, Nhu N. Q. Nguyen, Muhammad Yogi Pratama, Claudio Tiribelli Cancers.2021; 13(10): 2485. CrossRef
Cell‐to‐cell spread of vaccinia virus is promoted by
TGF
‐β‐independent Smad4 signalling
Anjali Gowripalan, Caitlin R. Abbott, Christopher McKenzie, Weng S. Chan, Gunasegaran Karupiah, Laurence Levy, Timothy P. Newsome Cellular Microbiology.2020;[Epub] CrossRef
Exosomal miRNAs: Novel Players in Viral Infection Javid Sadri Nahand, Maryam Mahjoubin-Tehran, Mohsen Moghoofei, Mohammad Hossein Pourhanifeh, Hamid Reza Mirzaei, Zatollah Asemi, Alireza Khatami, Farah Bokharaei-Salim, Hamed Mirzaei, Michael R Hamblin Epigenomics.2020; 12(4): 353. CrossRef
Tumor necrosis family receptor superfamily member 9/tumor necrosis factor receptor-associated factor 1 pathway on hepatitis C viral persistence and natural history Julia Peña-Asensio, Eduardo Sanz-de-Villalobos, Joaquín Miquel, Juan Ramón Larrubia World Journal of Hepatology.2020; 12(10): 754. CrossRef
Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma Mi Jeong Heo, Jessica Yun, Sang Geon Kim Archives of Pharmacal Research.2019; 42(1): 48. CrossRef
Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis Mousumi Khatun, Ratna B. Ray Cells.2019; 8(10): 1249. CrossRef
ZEB1 regulates the activation of hepatic stellate cells through Wnt/β-catenin signaling pathway Liang-yun Li, Chen-chen Yang, Jun-fa Yang, Hao-dong Li, Bo-yu Zhang, Hong Zhou, Shuang Hu, Kun Wang, Cheng Huang, Xiao-ming Meng, Huan Zhou, Lei Zhang, Jun Li, Tao Xu European Journal of Pharmacology.2019; 865: 172787. CrossRef
microRNAs as therapeutic targets in intestinal diseases Chen Wang, Jiangning Chen ExRNA.2019;[Epub] CrossRef
miRNAs regulate immune response and signaling during hepatitis C virus infection Huange Zhu, Yan Geng, Qian He, Miaoxian Li European Journal of Medical Research.2018;[Epub] CrossRef
Exendin-4 ameliorates high glucose-induced fibrosis by inhibiting the secretion of miR-192 from injured renal tubular epithelial cells Yijie Jia, Zongji Zheng, Meiping Guan, Qian Zhang, Yang Li, Ling Wang, Yaoming Xue Experimental & Molecular Medicine.2018; 50(5): 1. CrossRef
Dysregulation of cellular microRNAs by human oncogenic viruses – Implications for tumorigenesis Joana M.O. Santos, Rui M. Gil da Costa, Rui Medeiros Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms.2018; 1861(2): 95. CrossRef
According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
low
HCV-Specific CD8
+
Cell Reactivity
Elia Moreno-Cubero, Dolores Subirá, Eduardo Sanz-de-Villalobos, Trinidad Parra-Cid, Antonio Madejón, Joaquín Miquel, Antonio Olveira, Alejandro González-Praetorius, Javier García-Samaniego, Juan-Ramón Larrubia, Michael S. Diamond Journal of Virology.2018;[Epub] CrossRef
Hepatitis C virus–induced tumor‐initiating cancer stem–like cells activate stromal fibroblasts in a xenograft tumor model Reina Sasaki, Pradip Devhare, Ratna B. Ray, Ranjit Ray Hepatology.2017; 66(6): 1766. CrossRef
In order to express recombinant porcine TGF-β1 protein in a baculovirus expression system the entire TGF-β1 gene containing extra amino acids at the N terminus was cloned into pFBa and pFBb of the Bac-To-Bac^TM baculovirus expression system. One of the clones contained 106 extra amino acids and was designated pFBa-106 TGF-β1, and the other had 28 extra amino acids and was designated pFBb-28 TGF-β1. The orientation of the gene was identified with restriction enzyme mapping and PCR with internal TGF-β1 primers. Sf-9 cells were infected at a m.o.i. of 10 by the recombinant viruses generated from the two expected sizes of 55 kD and 46.4kD. these precursor forms of TGF-β1 with a polyclonal antibody against human TGF-β1. No mature form of TGF-β1 protein was detected on SDS gels and an immunoblot indicated that TGF-β1 precursor is not properlu processed in insect cells.